The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among other effects, the latest reduction in force of full-time FDA employees is raising concerns about the potential impact on drug and biologic manufacturing inspections....
By:
By: